Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer detection and diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announced today its H2 2026 financial communication calendar.
Date | |||
H1 2026 results | October 29, 2026, release
|
The Company will participate in upcoming investor events:
European MidCap Event 2026 September 30 October 1st, 2026 Paris, France
Investor Access Conference 2026 October 6-7, 2026 Paris, France
Portzamparc Biotech and Healthcare Sector Investor Seminar October 14-15, 2026 (digital)
Please get in touch through the respective event booking systems, if you would like to request a meeting with Median management at these events. Events are for institutional investors only.
About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis, an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260910527817/en/
Contacts:
MEDIAN TECHNOLOGIES
Emmanuelle Leygues
VP, Corporate Marketing
& Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Investors SEITOSEI ACTIFIN
Ghislaine Gasparetto
+33 6 85 36 76 81
ghislaine.gasparetto@seitosei-actifin.com
Media MAARC
Bruno Arabian
+33 6 87 88 47 26
bruno.arabian@maarc.fr
